Open Access Research Article Article ID: APRC-5-138

    A retrospective analysis of severe asthma treatment with Mepolizumab

    Mattia Serao*, Rossana Vigliarolo,Tiziana Trequattrini, Angela Succu, Marianna Lilli, Rosario Rivitti, Aldo Ciani, Giulia Cacciani, Sara Mannucci and Maria Cristina Zappa

    Among the different types of bronchial asthma, the allergic one is certainly the most easily found. Allergic asthma is characterized by the presence of IgE antibodies called “reagine”, responsible for triggering respiratory allergic crises in the presence of perennial or seasonal specifi c allergens.

    Allergic asthma with severe and persistent symptoms, with high levels of circulating IgE, can be treated with Omalizumab, a humanized monoclonal antibody obtained from recombinant DNA.


    Published on: Sep 24, 2019 Pages: 23-26

    Full Text PDF Full Text HTML DOI: 10.17352/aprc.000038
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on APRC